ULTRAGENYX PHARMACEUTICAL H-1B Visa Sponsorship & Salary Data

The median H-1B salary at ULTRAGENYX PHARMACEUTICAL is $134,826, based on 57 certified filings from FY 2020 to FY 2026. This is 12% higher than the national H-1B median salary of $120,000. Compensation at ULTRAGENYX PHARMACEUTICAL reflects their market positioning, with entry-level roles starting around $105,394 and senior positions reaching $200,000 or higher. These figures represent base salaries in LCA filings and may not include bonuses, equity grants, or other compensation common at large employers.

Salaries at ULTRAGENYX PHARMACEUTICAL range from $86,445 at the 10th percentile to $200,000 at the 90th percentile, showing a $113,555 spread across experience levels and roles. The 25th percentile is $105,394 and the 75th percentile is $164,694.

Yes, ULTRAGENYX PHARMACEUTICAL actively sponsors H-1B visas and has been a consistent participant in the H-1B program. They have filed 65 H-1B labor condition applications from FY 2020 to FY 2026, demonstrating ongoing commitment to hiring international talent. With 57 certified applications and a 0% denial rate, ULTRAGENYX PHARMACEUTICAL maintains a strong track record for H-1B sponsorship. The company sponsors positions across multiple job categories and locations, making them a viable option for professionals seeking H-1B visa sponsorship.

In the most recent fiscal year (FY 2026), ULTRAGENYX PHARMACEUTICAL filed 2 H-1B applications, with 2 certified and 0 denied. Over 7 years of data, ULTRAGENYX PHARMACEUTICAL has consistently demonstrated commitment to H-1B sponsorship.

Note: These are Labor Condition Applications (LCAs) filed with the Department of Labor, which is a prerequisite for H-1B petitions. The actual number of H-1B petitions filed with USCIS may differ.

ULTRAGENYX PHARMACEUTICAL's LCA (Labor Condition Application) denial rate is 0%, with 0 out of 65 applications denied across all years. This translates to a 100.0% certification rate, which indicates how successfully the company prepares and files H-1B applications. A lower denial rate suggests better compliance with Department of Labor requirements, proper wage documentation, and accurate job classification. Prospective H-1B applicants should consider this approval rate alongside other factors like salary, job role, and location when evaluating ULTRAGENYX PHARMACEUTICAL as a potential H-1B sponsor.

This is an excellent approval rate, indicating ULTRAGENYX PHARMACEUTICAL has strong H-1B sponsorship practices and typically meets DOL requirements. Applicants can feel confident in the company's H-1B track record.

ULTRAGENYX PHARMACEUTICAL sponsors H-1B visas for various specialty occupation positions requiring at least a bachelor's degree. Based on 57 certified filings, the most commonly sponsored job titles reflect the company's primary business functions and talent needs. These positions typically require specialized knowledge in fields like technology, engineering, finance, or scientific research. Understanding which roles ULTRAGENYX PHARMACEUTICAL most frequently sponsors can help job seekers target their applications effectively.

Most common H-1B job titles at ULTRAGENYX PHARMACEUTICAL:

The most frequently sponsored role is Research Scientist with 4 filings at a median salary of $105,394. This is followed by Senior Research Associate (2 filings) and Senior Associate, Regulatory Operations.

ULTRAGENYX PHARMACEUTICAL's H-1B positions are distributed across multiple U.S. locations, with concentration in major metropolitan areas and tech hubs. Geographic distribution often reflects company office locations, client sites, and regional market demands. Location significantly impacts H-1B salary due to varying cost of living and local wage requirements. Understanding where ULTRAGENYX PHARMACEUTICAL sponsors H-1B workers can help candidates target specific offices and negotiate appropriate compensation for each market.

Top ULTRAGENYX PHARMACEUTICAL H-1B locations:

The largest H-1B hub for ULTRAGENYX PHARMACEUTICAL is Bedford, MA with 12 filings at a median salary of $135,000. The highest-paying location is Novato, CA at $168,917 median. Salaries range from $85,000 to $168,917 across office locations.

ULTRAGENYX PHARMACEUTICAL's median H-1B salary has increased by +34% from FY 2020 ($105,394) to FY 2026 ($140,733). Tracking salary trends over time reveals how ULTRAGENYX PHARMACEUTICAL adjusts compensation to remain competitive in the H-1B labor market. Salary growth typically reflects inflation adjustments, increased demand for specialized skills, and evolving prevailing wage requirements. These historical trends can help applicants understand future salary expectations and negotiate appropriately when considering H-1B opportunities at ULTRAGENYX PHARMACEUTICAL.

Year-by-year breakdown:

• FY 2022: $128,752 (15 certified)
• FY 2023: $129,355 (10 certified)
• FY 2024: $181,813 (2 certified)
• FY 2025: $162,000 (8 certified)
• FY 2026: $140,733 (2 certified)

This 34% growth reflects strong compensation adjustments at ULTRAGENYX PHARMACEUTICAL, keeping pace with market demands for H-1B talent.

ULTRAGENYX PHARMACEUTICAL primarily files H-1B applications at Wage Level IV, accounting for 42% of their filings. DOL wage levels range from Level I (entry-level, 17th percentile of local wages) to Level IV (expert, 67th percentile). Wage level determines both salary requirements and, under recent H-1B rules, lottery selection priority. Higher wage levels receive preference in the H-1B lottery, making ULTRAGENYX PHARMACEUTICAL's wage level distribution an important factor for prospective applicants assessing their chances of H-1B selection.

With 85% of positions at Level II or higher, ULTRAGENYX PHARMACEUTICAL typically offers competitive wages above entry-level. Higher wage levels receive priority in the H-1B lottery.

ULTRAGENYX PHARMACEUTICAL's median H-1B salary of $134,826 is 12% higher than the national H-1B median of $120,000 across all employers and industries. This comparison provides context for evaluating ULTRAGENYX PHARMACEUTICAL's competitiveness in attracting H-1B talent. Keep in mind that industry, location, and job function significantly impact salary levels. Tech companies and financial institutions typically offer higher H-1B salaries than other sectors, while salaries in major metros like San Francisco and New York exceed those in smaller markets. Compare ULTRAGENYX PHARMACEUTICAL's offerings with similar companies in your field for a more accurate assessment.

ULTRAGENYX PHARMACEUTICAL offers above-average H-1B compensation. Combined with their 57 certified filings and 0% denial rate, they demonstrate solid H-1B sponsorship practices.

Recent H-1B rule changes have increased filing fees and introduced wage-level prioritization in the lottery. ULTRAGENYX PHARMACEUTICAL's higher proportion of Level III-IV positions (65%) may benefit from wage-based lottery prioritization.

With 57 certified filings, ULTRAGENYX PHARMACEUTICAL invests significantly in H-1B sponsorship. The company's 0% denial rate suggests strong compliance with H-1B requirements and documentation standards.

Note: H-1B regulations are subject to change. Fees shown are estimates based on 2024 USCIS fee schedules. Actual costs may vary based on company size, premium processing, and future rule changes.